Philippe Sauvage's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 39,999 Class A Common Stock done at an average price of $2.2 . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvation Bio Inc (Class A) | Philippe Sauvage | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.17 per share. | 15 Jul 2026 | 39,999 | 54,130 | - | 2.2 | 86,798 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Philippe Sauvage | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 39,999 | 662,333 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Philippe Sauvage | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 1 | 499,999 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Philippe Sauvage | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 15 Jul 2026 | 1 | 54,131 | - | 2 | 2 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Philippe Sauvage | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.17 per share. | 23 Jun 2026 | 47,668 | 60,341 | - | 2.2 | 103,440 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Philippe Sauvage | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2026 | 47,668 | 702,332 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Philippe Sauvage | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.01 per share. | 23 Jun 2026 | 47,668 | 12,673 | - | 6.0 | 286,370 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Philippe Sauvage | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 748,130 | 748,130 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Philippe Sauvage | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.79 per share. | 16 Jun 2025 | 4,000 | 9,902 | - | 1.8 | 7,160 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Philippe Sauvage | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.84 per share. | 16 Jun 2025 | 3,300 | 5,902 | - | 1.8 | 6,056 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Philippe Sauvage | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Philippe Sauvage | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2024 | 750,000 | 750,000 | - | - | Stock Option (Right to Buy) |